Detalhe da pesquisa
1.
First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 13(11): 1161-70, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23078958
2.
Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial.
EClinicalMedicine
; 48: 101432, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35706488
3.
Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial.
Lancet
; 371(9625): 1685-94, 2008 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-18486741
4.
The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma.
Lung Cancer
; 63(1): 94-7, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18486273
5.
The clinical role of VeriStrat testing in patients with advanced non-small cell lung cancer considered unfit for first-line platinum-based chemotherapy.
Eur J Cancer
; 120: 86-96, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31499384
6.
Phase II trial of irinotecan, cisplatin and mitomycin for relapsed small cell lung cancer.
Int J Cancer
; 121(11): 2575-7, 2007 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17680556
7.
Diffuse pleural mesothelioma with epithelioid and angiosarcomatous components--a hitherto undescribed pattern of differentiation.
Histopathology
; 60(7): 1164-6, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22385410
8.
In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion.
Clin Cancer Res
; 12(23): 7126-31, 2006 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17145837
9.
Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET).
J Clin Oncol
; 35(4): 402-411, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27893326
10.
Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1-Deficient Malignant Pleural Mesothelioma: A Randomized Clinical Trial.
JAMA Oncol
; 3(1): 58-66, 2017 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27584578
11.
Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials.
J Clin Oncol
; 23(1): 184-9, 2005 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15625372
12.
A randomised comparison of radical radiotherapy with or without chemotherapy for patients with non-small lung cancer: results from the Big Lung Trial.
Radiother Oncol
; 75(2): 134-140, 2005 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16094738
13.
Prognostic factors in mesothelioma.
Lung Cancer
; 49 Suppl 1: S49-52, 2005 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15894403
14.
Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma.
Lung Cancer
; 47(2): 277-81, 2005 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15639727
15.
Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes.
Chest
; 123(1 Suppl): 97S-104S, 2003 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-12527569
16.
The physiologic evaluation of patients with lung cancer being considered for resectional surgery.
Chest
; 123(1 Suppl): 105S-114S, 2003 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-12527570
17.
Chemotherapy and radiotherapy of bronchial carcinoma.
Hosp Med
; 64(3): 144-9, 2003 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-12669480
18.
Pulmonary toxicity and cancer treatment.
Hosp Med
; 65(8): 462-5, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15330346
19.
Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data.
J Clin Oncol
; 30(14): 1692-8, 2012 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22473169
20.
Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma.
Eur J Cancer
; 48(16): 2983-92, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22704893